Science Explorer Back to mapMap
Discussion
Institution · Otsuka (France)

Most cited papers from Otsuka (France)

Otsuka (France)

What are the most cited papers from Otsuka (France)?

The most cited paper from Otsuka (France) is "Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial" (W. Wolfgang Fleischhacker, Martti E. Heikkinen, Jean‐Pierre Olié et al., 2010), with 198 citations. Next come "The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913)" (85) and "Residual symptoms and functional performance in a large sample of euthymic bipolar patients in France (the OPTHYMUM study)" (42).

Showing 43 of 43 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial W. Wolfgang Fleischhacker, Martti E. Heikkinen, Jean‐Pierre Olié et al. · The International Journal of Neuropsychopharmacology Open access 12 May 2010 198
2 The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913) Linda Hanssens, Gilbert J L'Italien, Jean‐Yves Loze et al. · BMC Psychiatry Open access Dec 2008 85
3 Residual symptoms and functional performance in a large sample of euthymic bipolar patients in France (the OPTHYMUM study) Ludovic Samalin, Pierre‐Michel Llorca, Bruno Giordana et al. · Journal of Affective Disorders 22 Feb 2014 42
4 Real-world effectiveness of long-acting injectable antipsychotic treatments in a nationwide cohort of 12,373 patients with schizophrenia-spectrum disorders Laurent Boyer, Bruno Falissard, Philippe Nuss et al. · Molecular Psychiatry Open access 21 Jul 2023 41
5 Defining the minimal clinically important difference (MCID) of the Heinrichs-carpenter quality of life scale (QLS) Bruno Falissard, Christophe Sapin, Jean‐Yves Loze et al. · International Journal of Methods in Psychiatric Research Open access 4 Aug 2015 33
6 Cost-effectiveness of atypical antipsychotics for the management of schizophrenia in the UK Andrew Davies, Kawitha Vardeva, Jean‐Yves Loze et al. · Current Medical Research and Opinion 22 Oct 2008 29
7 Évolution de l’autonomie sociale chez des patients schizophrènes selon les prises en charge. L’étude ESPASS Denis Leguay, F. Rouillon, Jean‐Michel Azorin et al. · L Encéphale 12 Mar 2010 24
8 Patients’ Perspectives on Residual Symptoms in Bipolar Disorder Ludovic Samalin, Frank Bellivier, Bruno Giordana et al. · The Journal of Nervous and Mental Disease 12 Jun 2014 23
9 UK cost-consequence analysis of aripiprazole in schizophrenia: diabetes and coronary heart disease risk projections (STAR study) Anthony H Barnett, Helen L. Millar, Jean‐Yves Loze et al. · European Archives of Psychiatry and Clinical Neuroscience 9 Mar 2009 22
10 How can we improve the care of patients with schizophrenia in the real-world? A population-based cohort study of 456,003 patients Guillaume Fond, Bruno Falissard, Philippe Nuss et al. · Molecular Psychiatry Open access 21 Jul 2023 17
11 Preference of medicine and patient-reported quality of life in community-treated schizophrenic patients receiving aripiprazole vs standard of care: Results from the STAR study David M. Taylor, Linda Hanssens, Jean‐Yves Loze et al. · European Psychiatry 19 Apr 2008 16
12 Cost-effectiveness analysis of aripiprazole vs standard-of-care in the management of community-treated patients with schizophrenia: STAR study Derek King, Martin Richard John Knapp, Pierre M. Thomas et al. · Current Medical Research and Opinion 20 Dec 2010 12
13 Long-term efficacy and safety of Aripiprazole in children (10-17 yo) with mania Margaretta Nyilas, Andrew Benjamin Forbes, J.Y. Loze et al. · European Psychiatry 29 Mar 2008 12
14 Pratiques thérapeutiques dans la prise en charge des patients souffrant de troubles bipolaires en France. Étude TEMPPO P. Nuss, W. de Carvalho, Patrick Blin et al. · L Encéphale 9 Dec 2011 10
15 How to improve adherence to antipsychotic treatment: Outcomes of the IMproving PAtient outComes in psychiaTry (IMPACT) Berlin 2009 meeting workshop Siegfried F. Kasper, Laurence Saya, Beril Tekin et al. · International Journal of Psychiatry in Clinical Practice 2009 8
16 Caractéristiques sociodémographiques et cliniques de patients souffrant de troubles bipolaires suivis en ambulatoire en France métropolitaine W. de Carvalho, P. Nuss, Patrick Blin et al. · L Encéphale Jun 2012 5
17 Niveau de vigilance des psychiatres pour les facteurs de risque cardiovasculaire chez les patients schizophrènes F. Rouillon, Éric Van Ganse, P. Vekhoff et al. · L Encéphale 27 Jan 2015 5
18 L’initiation thérapeutique dans les épisodes psychotiques et maniaques : recueil des attitudes françaises par Focus Group Michel Benoît, Frank Bellivier, P.-M. Llorca et al. · L Encéphale 29 May 2012 4
19 Schizophrenia: Study of Epidemiological and Economic Regional Disparities PG Larroumets · Value in Health Open access Sep 2018 2
20 Analyse coût-efficacité de l’aripiprazole injectable à libération prolongée (AILP) comparé au palmitate de palipéridone (PP) dans le traitement de la schizophrénie en France Guy Gozlan, Laurent Lecardeur, Anne-Solène Monfort et al. · L Encéphale Open access 26 Oct 2018 2
21 A prospective, multicentre, open-label study to evaluate the effectiveness of aripiprazole in the treatment of a broad range of patients with schizophrenia J. Peuskens, Chris Bervoets, Frank Kok et al. · European Psychiatry 15 Sep 2011 2
22 A comparision of switching strategies from risperidone to aripiprazole in patients with schizophrenia with insufficient efficacy/tolerability on risperidone (cn138-169) V. Rykmans, J.P. Kahn, Anne Dillenschneider et al. · European Psychiatry 29 Mar 2008 2
23 2288 – A 12-week, Randomized, Placebo-controlled Study Evaluating The Efficacy And Safety Of Aripiprazole In Combination With Lithium/valproate Inpartially-responsive Bipolar Mania J.-Y. Loze, Wally Landsberg, Lætitia Rollin et al. · European Psychiatry 2013 1
24 A 16-week, Multicentre, Randomized, Open-label Study Assessing Effects of Aripiprazole Versus other Atypicals for Schizophrenia Patients with Metabolic Syndrome H. Day-Poulsen, Pierre Thomas, J.-Y. Loze et al. · European Psychiatry Open access 2009 1
25 Impacts des crises sur la qualité de vie des patients atteints d’angioedème héréditaire : Résultats d’une étude européenne L. Bouillet, G. Luppino, Charlotte Heeks et al. · La Revue de Médecine Interne 25 Nov 2025 0
26 Traitement par tolvaptan dans la polykystose rénale autosomique dominante : aspects pratiques Blandine Boisselier, Chauveau, Dominique, Dominique Guerrot et al. · HAL (Le Centre pour la Communication Scientifique Directe) Sep 2019 0
27 Analyse des discussions des patients atteints de néphrite lupique à partir des forums publics de l’internet en France Marianne Rivière, Charles Personnic, Geoffroy Sainte‐Claire Deville · Néphrologie & Thérapeutique Sep 2022 0
28 Analyse des discussions des patients atteints de lupus à partir des forums publics de l’internet en France M. Riviere, C. Personnic, G. Sainte-Claire Deville · La Revue de Médecine Interne Jun 2022 0
29 Polykystose rénale : analyse des discussions des e-patients sur la blogosphère publique C. Lagrafeil, Mélanie Hueber, T. Barhogel et al. · Néphrologie & Thérapeutique Sep 2015 0
30 Profil des patients atteints de polykystose rénale autosomique dominante au stade d’IRC : enquête de pratique auprès de néphrologues français Gabriel J. Choukroun, Mélanie Hueber, Thomas Marquet · Néphrologie & Thérapeutique Sep 2014 0
31 Evaluation of Dyslipidaemia Risk among Patients Treated with Aripiprazole: Meta Analysis of Placebo- and Olanzapine-controlled Studies Hélène Peyro-Saint-Paul, J.-Y. Loze, Stephen Kaplita et al. · European Psychiatry Open access 2009 0
32 P01-38 - Efficacy of Adjunctive Aripiprazole in Patients with Major Depressive Disorder: Pooled Analysis of Subgroup Data from Three Clinical Trials Rossella Gismondi, Robert D. McQuade, J.-Y. Loze et al. · European Psychiatry 2010 0
33 Validation of a scale measuring patient satisfaction with psychotropic treatment (pasap) on a sample of schizophrenic patients - espass study I. Gasquet, D. Legay, Jean Michel Azorin et al. · European Psychiatry 29 Mar 2008 0
34 P01-58 - Adjunctive Aripiprazole in Patients with Major Depressive Disorder: Pooled Data on Functioning from three Clinical Trials J.-Y. Loze, Rossella Gismondi, Ross A. Baker et al. · European Psychiatry 2010 0
35 EVALUATION OF THE EFFECT OF ARIPIPRAZOLE ON VERBAL COGNITIVE FUNCTIONING IN A BROAD RANGE OF PATIENTS WITH SCHIZOPHRENIA IN A PROSPECTIVE, MULTICENTRE, OPEN-LABEL STUDY Chris Bervoets, E. Constant, Bernard Sabbe et al. · Schizophrenia Research 21 Mar 2010 0
36 PW01-11 - Effect of Adjunctive Aripiprazole on Quality of Life in Patients With Major Depressive Disorder: Pooled Data From Three Clinical Trials Rossella Gismondi, J.-Y. Loze, Ross A. Baker et al. · European Psychiatry Open access 2010 0
37 P01-57 - Analysis of Pooled Safety Data from three Randomized, Double-blind, Placebo-controlled Studies of Adjunctive Aripiprazole in Major Depressive Disorder J.-Y. Loze, Rossella Gismondi, Robert D. McQuade et al. · European Psychiatry Open access 2010 0
38 PW01-60 - Similar Short- And Long-Term Efficacy Results Of Aripiprazole In Post-Pubertal Adolescents (Ages 15-17) And Adults With Schizophrenia J.-Y. Loze, Christoph Ulrich Correll, Wally Landsberg et al. · European Psychiatry 2010 0
39 P01-39 - Adjunctive Aripiprazole in Patients with Major Depressive Disorder: Efficacy Data from three Short-term Studies Rossella Gismondi, Robert D. McQuade, J.-Y. Loze et al. · European Psychiatry Open access 2010 0
40 PW01-36 - The Long-term Safety, Tolerability And Effectiveness Of Adjunctive Aripiprazole To Lithium/valproate In Bipolar i Patients Partially Non-responsive To Mood Stabilisers Eduard Vieta, Randall Owen, Christine Baudelet et al. · European Psychiatry 2010 0
41 Efficacy and tolerability of aripiprazole in adolescents with schizophrenia Andrew Benjamin Forbes, Margaretta Nyilas, J.-Y. Loze et al. · European Psychiatry 29 Mar 2008 0
42 PW01-20 - Adjunctive Aripiprazole in Patients with Major Depressive Disorder: Pooled Safety and Tolerability Data from Three Short-Term Studies J.-Y. Loze, Rossella Gismondi, Robert D. McQuade et al. · European Psychiatry Open access 2010 0
43 Polykystose rénale : analyse des discussions des e-patients sur la blogosphère publique Corinne Lagrafeuil, Mélanie Hueber, Xavier Magnien et al. · Néphrologie & Thérapeutique 27 Apr 2017 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.